• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Over-the-Counter Diagnostic Products World Markets - Product Image

Over-the-Counter Diagnostic Products World Markets

  • ID: 2296020
  • October 2012
  • Region: Global
  • 398 Pages
  • TriMark Publications

FEATURED COMPANIES

  • A Menarini Diagnostics
  • AgaMatrix
  • Ani Biotech Oy
  • Becton Dickinson (BD)
  • HemoCue
  • Johnson & Johnson
  • MORE

The purpose of this TriMark Publications analysis is to describe the specific market segments of the over-the-counter (OTC) diagnostic products and home healthcare markets. It examines the diagnostic measurement devices and their reagents and supplies that are utilized in clinics and by patients directly in their homes to diagnose and monitor disease. This study also includes a review of home healthcare kits and devices that measure health-related conditions. Focus is on market dynamics and current market drivers of the OTC and home self-testing diagnostics market.

This report also looks at the industry challenges and potential threats, and it makes strategic recommendations for boosting market share. The analysis covers healthcare-related devices that are designed for the home market in order to allow consumers to assess their health status through self-testing. In addition, this review examines some biowarfare detection systems. The emphasis in this report is on those companies and products that are actively developing and marketing diagnostic reagents and supplies in market segments that are targeted for direct sale to the public.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • A Menarini Diagnostics
  • AgaMatrix
  • Ani Biotech Oy
  • Becton Dickinson (BD)
  • HemoCue
  • Johnson & Johnson
  • MORE

1. Overview
1.1 Statement of Report
1.2 About This Report
1.3 Scope of the Report
1.4 Objectives
1.5 Methodology
1.6 Executive Summary

2. Sector Overview
2.1 Global Diagnostic Products Industry
2.2 Global OTC Diagnostic Products Industry
2.3 European OTC and Home Self-Testing Diagnostic Markets
2.3.1 German OTC and Home Self-Testing Diagnostic Markets
2.3.2 U.K. OTC and Home Self-Test Diagnostic Markets
2.3.2.1 U.K. Market Statistics
2.3.2.2 U.K. Competitive Analysis
2.3.2.3 U.K. Market Access
2.3.3 French OTC Diagnostic Market
2.3.4 Italian OTC Diagnostic Market
2.3.5 Spanish OTC Diagnostic Market
2.3.6 Japanese OTC Diagnostic Market
2.3.7 Chinese OTC Diagnostic Market
2.4 Description of the U.S. OTC Diagnostics Industry Segment
2.4.1 Market Overview
2.4.2 Diagnostic Test Categories
2.5 Market Drivers in the OTC Diagnostics Sector
2.5.1 Overview
2.5.2 Market Segments
2.6 Key Players in the OTC Diagnostics Segment
2.7 Sector Analysis

3. Market Analysis: Size, Growth, Share and Competitors
3.1 Glucose Monitoring
3.1.1 Glucose Control in Diabetic Patients
3.1.2 Tight Glucose Control in Treating Diabetes
3.1.3 Glucose-Monitoring Devices
3.1.4 Key Issues for Glucose Monitoring
3.1.5 Glucose Device Description
3.1.6 Precision in Glucose Meters
3.1.7 Limitations of Existing Glucose Monitoring Products
3.1.8 Over-the-Counter (OTC) Self-Testing Glucose Market
3.1.9 Worldwide Glucose Testing Market
3.1.9.1 U.S. Market
3.1.9.2 European Market
3.1.9.3 Asia-Pacific (Excluding Japan)
3.1.9.3.1 Japanese Market
3.1.9.3.2 Chinese Market
3.1.9.3.3 Indian Market
3.1.9.4 ROW Markets
3.1.10 Reagents and Equipment
3.1.10.1 Blood Glucose Monitoring
3.1.10.2 Lancets
3.1.10.3 Blood Glucose Monitor and Insulin Doser
3.1.10.4 Blood Glucose Reagent Test Strips
3.1.10.5 Control Solutions and Calibrators
3.1.10.6 Sharps Devices
3.1.10.7 Needle Destruction Devices
3.1.11 Glucose Meters
3.1.12 Voice-Operated Glucose Meters
3.1.13 Continuous Blood Glucose Monitoring (CBGM)
3.1.14 Self-Monitoring Blood Glucose (SMBG) Testing
3.1.15 Minimally-Invasive and Non-Invasive Blood Glucose Testing
3.1.16 Emerging Glucose Monitoring Technologies
3.1.16.1 Optical Transducer Technologies
3.1.16.2 Transdermal Sensor Technologies
3.1.16.3 Invasive Glucose Sensor Technologies
3.2 Pregnancy and Fertility Testing
3.2.1 Major Players
3.2.1.1 U.S. Market
3.2.1.2 European Market
3.2.2 Diagnostic Kit Information
3.2.3 Competitive Sector Analysis
3.3 Hepatitis Testing
3.4 Drugs of Abuse Screening Testing
3.5 Infectious Disease Testing
3.5.1 HIV
3.5.2 Tuberculosis Testing
3.5.3 Infectious Disease Testing in Non-Medical Settings
3.5.4 West Nile Virus
3.5.5 Urinary Tract Infections
3.6 Cholesterol Testing
3.7 Coagulation Testing
3.8 Urine Dipstick Testing
3.9 Fertility Testing
3.9.1 Players
3.9.2 Diagnostic Test Kits
3.10 At-Home DNA Analysis
3.11 Biowarfare Detection
3.12 Home Patient Monitoring Devices
3.13 Home Patient Alert Systems
3.14 Home Genetic Testing Kits
3.15 Home Paternity Testing
3.16 Health Hazards Detection
3.16.1 Lead
3.16.2 Radon
3.16.3 Asbestos
3.16.4 Pesticides
3.16.5 Mold
3.16.6 Carbon Monoxide
3.16.7 Water Quality
3.16.8 Bacteria in Water
3.17 Thyroid Disease
3.18 Carpal Tunnel
3.19 Allergies
3.20 Nutrition and Wellness
3.20.1 Testosterone and Male Hormones
3.20.2 Female Hormones
3.20.3 Antioxidants
3.20.4 Sleep Apnea
3.20.5 Mineral Check
3.20.6 Stress Check
3.21 Colorectal Cancer (Occult Blood) Testing
3.22 Alzheimer’s Disease Home Screening Test
3.23 Tobacco Testing

4. Business Trends in the Industry
4.1 Wholesale Distribution Overview
4.2 Factors Affecting OTC Medical Product Distribution
4.3 Government Regulation of Medical Devices
4.3.1 U.S. Regulations
4.3.2 U.K. Regulations
4.4 Clinical Laboratory Improvement Act (CLIA)
4.5 Legal, M&A and Corporate Partnerships

5. Patient Management Trends
5.1 Trends in OTC Testing and Reimbursement
5.1.1 American OTC Testing and Home Self-testing Reimbursement
5.1.2 European Reimbursement
5.2 Drivers of OTC and Home Self-Testing
5.3 Cost Elements of OTC Testing
5.4 Important Elements of OTC Testing
5.5 Growth of Home Care Testing
5.6 Non-Traditional Methods for Sample Collection

6. Technology Trends
6.1 Sensor Systems for Diagnostic Applications
6.2 Glucose Measurements
6.3 Cholesterol Testing
6.4 Immunoassay Technology
6.5 Biosensor Technology
6.5.1 Recent Biosensor Product Introductions and Latest Innovative Developments
6.5.1.1 Nanoscale Sensors for the Detection of Cancer Biomarkers
6.5.1.2 ForteBio Introduces Dip and Read Protein G Biosensor for Octet Instruments
6.5.1.3 ForteBio Launches New Octet RED96 System and Dip and Read Protein L Biosensor
6.5.1.4 AgaMatrix Europe Limited introduces the New Jazz Blood Glucose Meter in the U.K.
6.5.1.5 STMicroelectronics to Manufacture Worlds Smallest Biosensors
6.5.1.6 Universal Biosensors Advances Point of Care Molecular Diagnostic Opportunity
6.5.1.7 Clinitek Advantus—A Semi Automated Urine Analyzer for Point of Care Testing
6.5.1.8 The NOVA 16 STAT Chemistry Analyzer Offers the First All-Electrode-based Seven Test Chemistry Profile
6.6 Fructosamine Test
6.7 Home Telemedicine Devices
6.8 Insulin Pumps

7. OTC Testing: Critical Issues
7.1 Moderators of Growth for OTC Testing
7.2 Attitudes of Critical Care Nurses and Physicians
7.3 Personnel Impact for OTC Testing
7.4 Data Management Issues
7.5 POC Decentralization Issues
7.6 POC Testing and Clinical Outcomes
7.7 Focused Testing
7.8 Satellite Facilities
7.9 POC Testing Comparison and Cost Analysis

8. Competitive Assessments of the High-Growth Markets
8.1 Glucose Monitoring
8.1.1 Overview of Market Segment
8.1.2 Competitive Strategies
8.1.3 Analyses of the Current Market Conditions, Competition and Product Mix
8.1.4 Adjacent Markets
8.1.5 Market Drivers and Restraints
8.1.6 Market and Product Trends
8.2 Coagulation Testing
8.2.1 Overview of Market Segment
8.2.2 Competitive Strategies
8.2.3 Analyses of Current Market Conditions
8.2.4 Product Mix in Coagulation Testing
8.2.4.1 Review of Selected POC Rapid Coagulation Analyzers
8.2.5 Adjacent Markets
8.2.6 Market Drivers and Restraints
8.2.7 Market and Product Trends
8.2.8 Quality Control Issues
8.3 Cholesterol Testing
8.3.1 Overview of Market Segment
8.3.2 Competitive Strategies
8.3.3 Adjacent Markets
8.4 Infectious Disease Testing
8.4.1 Overview of Market Segment
8.5 Drugs of Abuse
8.5.1 Overview of Market Segment
8.5.2 Analyses of the Current Market Conditions, Competition and Product Mix
8.5.2.1 Alere
8.5.2.2 Abbott Diagnostics
8.5.2.3 Roche Diagnostics
8.5.2.4 BioScan Screening Systems, Inc.
8.5.2.5 American Bio Medica Corp.
8.5.2.6 Phamatech, Inc.
8.5.2.7 First Check Medical (Inverness Medical Innovations, Inc.)
8.5.2.8 OraSure
8.5.2.9 Avitar, Inc.
8.5.2.10 Concateno
8.5.2.11 Pathtech
8.5.2.12 Alfa Scientific Designs, Inc.
8.5.2.13 TCPI, Inc.
8.5.2.14 Roche
8.5.2.15 Biophor Diagnostics
8.5.2.16 Randox Laboratories
8.5.2.17 Branan Medical
8.5.2.18 Concateno
8.5.3 Adjacent Markets
8.6 Home Pregnancy Testing
8.6.1 Overview of Market Segment
8.6.2 Competitive Strategies
8.6.3 Analysis of Current Market Conditions
8.6.4 Product Mix
8.6.5 Adjacent Markets
8.6.6 Market Drivers and Restraints
8.6.7 Market and Product Trends

9. Current Issues for OTC and Home Diagnostic Testing
9.1 New Markets for OTC and Home Diagnostic Testing
9.2 Utility of OTC and Home Self-Testing
9.3 Corporate Screening
9.4 Generational Drivers of Home Testing
9.5 Move Away from Central Laboratories
9.6 Healthcare Cost Controls
9.7 Mergers of Diagnostic Companies
9.8 Home Healthcare Trends
9.9 Home Healthcare Providers versus Mass Market Retailers
9.10 Demographic Merchandising
9.11 Marketing Strategies
9.12 Third-Party Pharmacy Networks
9.13 Which Customer Segments Purchase Home Healthcare? Which Products Fit Their Needs?
9.14 Future of Patient Self-Testing

10. Corporate Profiles
10.1 Abbott Diagnostics
10.2 ACON Laboratories, Inc.
10.3 AgaMatrix
10.4 Alere, Inc.
10.5 American Bio Medica Corporation (ABMC)
10.6 AmeriSourceBergen
10.7 Ani Biotech Oy
10.8 ARKRAY, Inc.
10.9 Bayer Corporation
10.10 Becton Dickinson (BD)
10.11 Biomerica, Inc.
10.12 Calypte Biomedical Corporation
10.13 Cardinal Health, Inc.
10.14 HemoCue
10.15 Home Access Health Corp.
10.16 Insulet Corporation
10.17 International Technidyne Corporation (ITC) Nexus Dx
10.18 Johnson & Johnson
10.19 LifeScan
10.20 A Menarini Diagnostics
10.21 NOVA Biomedical
10.22 Orasure
10.23 Princeton BioMeditech
10.24 Quidel Corp.
10.25 Roche Diagnostics (a Division of Roche Holdings)
10.26 Saliva Diagnostics
10.27 Trinity Biotech, Plc

11. Corporate Directory

Appendix 1: Over-the-Counter In Vitro Diagnostic Devices
Appendix 2: Recent OTC Waived Tests for Drugs of Abuse
Appendix 3: FDA Approved and Unapproved Tests for HIV Home Testing
Appendix 4: Home Medical Equipment Reimbursement Contacts for Medicare
Appendix 5: Frequently-Asked Questions About Drug Screening Kits

INDEX OF FIGURES

Figure 2.1: European OTC Diagnostic Products Market by Country
Figure 3.1: Single-Day Continuous Blood Glucose Data
Figure 3.2: Share of the U.S. Self-Testing Diagnostic Market, 2011
Figure 7.1: Conformity Assessment Route, Annexes and Quality System Standards by IVD Device Category
Figure 8.1: Coagulation Testing

INDEX OF TABLES

Table 2.1: Worldwide Distribution of IVD Testing, 2011
Table 2.2: Top 13 Country IVD Testing Markets, 2011
Table 2.3: Total Global POCT Market, 2008-2018
Table 2.4: Global POC Market Share Analysis, 2011
Table 2.5: Worldwide OTC Diagnostic Products Market, 2008-2018
Table 2.6: Worldwide OTC Diagnostic Products Market by Region, 2011
Table 2.7: European OTC Diagnostic Products Market, 2008-2018
Table 2.8: Major European OTC Diagnostics Markets, 2011
Table 2.9: German OTC Diagnostic Products Market Sales, 2008-2018
Table 2.10: U.K. OTC Diagnostic Products Market Sales, 2008-2018
Table 2.11: Major U.K. Suppliers of IVD Products
Table 2.12: French OTC Diagnostic Products Market Sales, 2008-2018
Table 2.13: Italian OTC Diagnostic Products Market Sales, 2008-2018
Table 2.14: Spanish OTC Diagnostic Products Market Sales, 2008-2018
Table 2.15: Japanese OTC Diagnostic Products Market Sales, 2008-2018
Table 2.16: Chinese OTC Diagnostic Products Market Sales, 2008-2018
Table 2.17: U.S. OTC Diagnostic Products Market Sales, 2008-2018
Table 2.18: U.S. Clinical Diagnostic Home Test Market Segments, 2011
Table 2.19: Top Drugstore Retailers in the U.S.
Table 2.20: Top Drugstore Wholesalers in the U.S.
Table 3.1: Global Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 3.2: U.S. Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 3.3: Top Ten Countries in Number of Persons with Diabetes (Aged 20 to 79 Years), 2011 and 2030
Table 3.4: Share of the U.S. Self-Testing Diagnostic Market, 2011
Table 3.5: OTC Blood Glucose Instrument Reagents by Manufacturer Retail
Table 3.6: World Market Share of POC Glucose Monitoring Marketers
Table 3.7: Key Features Considered for Glucose Meter Devices
Table 3.8: Demographic Characteristics Home-Testing Kit Buyers
Table 3.9: Top Brand Preferences for Home Glucose Testing Kits
Table 3.10: Instances When Patients Prefer Professional’s Glucose Testing
Table 3.11: Advantages of a Home-Testing Kit
Table 3.12: Disadvantages of Using a Home-Testing Kit
Table 3.13: Popular Shopping Destinations for Buying or Seeking Information on Home Testing Kits
Table 3.14: Worldwide Glucose Self-Testing Market Sales (Meters, Strips, Lancets), 2008-2018
Table 3.15: U.S. Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 3.16: OTC Glucose Meter U.S. Market Share for Blood Glucose Measurements
Table 3.17: U.S. Diabetes Glucose Monitoring Market Repeat Retail Replacement Sales Percentages
Table 3.18: Top Four Players in the U.S. Blood Glucose Strips Market—Ranked by Percentage Sales, 2011
Table 3.19: Leading Blood Glucose Meters and Strips Brands in the U.S., 2011
Table 3.20: European Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 3.21: European Glucose Self-Testing Market by Country, 2011
Table 3.22: Asia-Pacific (Excluding Japan) Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 3.23: Japan Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 3.24: Chinese Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 3.25: Chinese Glucose Self-Testing Market (Test Strips), 2008-2018
Table 3.26: Indian Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 3.27: Indian Glucose Self-Testing Market (Test Strips), 2008-2018
Table 3.28: ROW Glucose Self-Testing Market (Meters, Strips, Lancets), 2008-2018
Table 3.29: Unit Sales of Homecare Lancets in the U.S., 2008-2018
Table 3.30: Unit Sales of Lancets in the E.U., 2008-2018
Table 3.31: Competition in the Lancet Market Segment
Table 3.32: Key Features of Reagent Test Strips
Table 3.33: Customer Priorities—Glucose Meter Self-Testing Market, 2001, 2006 and 2012
Table 3.34: Accu-Chek Blood Glucose Monitoring Systems
Table 3.35: Summary of Emerging Glucose Sensor Technologies, 2011
Table 3.36: Pregnancy Test Market for OTC Testing in the U.S., 2008-2018
Table 3.37: Pregnancy Test Market for OTC Testing in Europe, 2008-2018
Table 3.38: U.S. Market Share for Home Pregnancy Tests
Table 3.39: European Market Share for OTC Pregnancy Tests
Table 3.40: Home Pregnancy Tests Available in the U.S. Market
Table 3.41: Hepatitis C Statistics
Table 3.42: Hepatitis Market for OTC Testing in the U.S., 2008-2018
Table 3.43: U.S. OTC Drugs of Abuse Testing Market in the U.S., 2008-2018
Table 3.44: Illicit Drugs that are Important for Detection
Table 3.45: Analytical Detection Levels for Drugs of Abuse
Table 3.46: Princeton BioMeditech’s Drugs of Abuse Tests
Table 3.47: Abbott Drugs of Abuse Tests on the ARCHITECT System
Table 3.48: Infectious Disease Market for OTC Testing in the U.S., 2008-2018
Table 3.49: HIV Testing Market for OTC Testing in the U.S., 2008-2018
Table 3.50: Home Testing for Urinary Tract Infections
Table 3.51: Cholesterol Market for OTC and Home Self-Testing in the U.S., 2008-2018
Table 3.52: Coagulation Market for OTC Testing in the U.S., 2008-2018
Table 3.53: Global Urine Dipstick Testing OTC Testing., 2008-2018
Table 3.54: Glucose Market for OTC Testing in the U.S., 2008-2018
Table 3.55: Fertility Testing Market for OTC Testing in the U.S., 2008-2018
Table 3.56: Fertility Testing Market for OTC Testing in Europe, 2008-2018
Table 3.57: Rite Aid and Other OEM Ovulation Predictors
Table 3.58: At-Home DNA Tests
Table 3.59: At-Home DNA Market for OTC Testing Worldwide, 2008-2018
Table 3.60: Home Genetic Testing Market in the U.S., 2008-2018
Table 3.61: Genovations Profiles
Table 3.62: Featured Tests by DNA Direct
Table 3.63: Fee Schedule for Personal Home-based Paternity Studies
Table 4.1: Financial Comparison for Moderate and Waived CLIA Labs
Table 6.1: Normal Glucose Values, Fasting State
Table 6.2: Cholesterol Levels and Desirability
Table 6.3: Leading Home Patient Monitoring Products in the U.S. Market
Table 7.1: POC Testing: Cost Analysis
Table 7.2: POC Testing: Cost Analysis with Labor Included
Table 8.1: Global Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 8.2: Global Glucose Self-Testing Market (Meters), 2008-2018
Table 8.3: Global Glucose Self-Testing Market (Lancets), 2008-2018
Table 8.4: Global Glucose Self-Testing Market (Test Strips), 2008-2018
Table 8.5: U.S. Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 8.6: U.S. Glucose Self-Testing Market (Meters), 2008-2018
Table 8.7: U.S. Glucose Self-Testing Market (Lancets), 2008-2018
Table 8.8: U.S. Glucose Self-Testing Market (Test Strips), 2008-2018
Table 8.9: U.S. OTC Glucose Self-Testing Market Repeat Retail Replacement Sales Percentages, 2011
Table 8.10: Market Share of U.S. Blood Glucose Self-Testing, 2011
Table 8.11: European Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 8.12: European Glucose Self-Testing Market (Meters), 2008-2018
Table 8.13: European Glucose Self-Testing Market (Lancets), 2008-2018
Table 8.14: European Glucose Self-Testing Market (Test Strips), 2008-2018
Table 8.15: European Glucose Self-Testing Market by Country, 2011
Table 8.16: Asia-Pacific (Excluding Japan) Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 8.17: Asia-Pacific (Excluding Japan) Glucose Self-Testing Market (Meters), 2008-2018
Table 8.18: Asia-Pacific (Excluding Japan) Glucose Self-Testing Market (Lancets), 2008-2018
Table 8.19: Asia-Pacific (Excluding Japan) Glucose Self-Testing Market (Test Strips), 2008-2018
Table 8.20: Japanese Population and Aging Demographics Forecast, 2000-2050
Table 8.21: Japan Glucose Self-Testing Market (Meters, Lancets and Test Strips), 2008-2018
Table 8.22: Key Market Drivers for Glucose Self-Testing
Table 8.23: Market Drivers for Continuous Glucose Monitoring
Table 8.24: Key Market Restraints for Glucose Self-Testing
Table 8.25: Market Restraints for Continuous Glucose Monitoring
Table 8.26: U.S. Revenue Forecasts for POC Rapid Coagulation Analyzer Systems, 2008-2018
Table 8.27: Selected POC Rapid Coagulation Analyzers, 2011
Table 8.28: Global Revenue Forecasts for POC Cholesterol Testing Products Market, 2008-2018
Table 8.29: U.S. Revenue Forecasts for POC Cholesterol Testing Products Market, 2008-2018
Table 8.30: European Revenue Forecasts for POC Cholesterol Testing Products Market, 2008-2018
Table 8.31: Selected POC Substance/Drug Abuse Testing Devices, 2011
Table 9.1: Instruments Available for INR Self-Testing
Table 9.2: INR PST Service Providers
Table 9.3: PST Reimbursement, 2011
Table 9.4: Future Strategies for INR Testing
Table 10.1: Alere, Inc. Financial Figures—Net Sales by Business Sector, 2008-2011
Table 10.2: Alere, Inc. Financial Figures—Net Sales by Geographic Region, 2008-2011
Table 10.3: AmerisourceBergen Financial Figures—Statement of Operations Data, 2008-2011
Table 10.4: Bayer AG Financial Figures—Net Sales by Business Sector, 2008-2011
Table 10.5: Bayer AG Financial Figures—Net Sales by Geographic Region, 2008-2011
Table 10.6: Cardinal Health Financial Figures—Net Sales by Business Sector, 2009-2011
Table 10.7: Cardinal Health Financial Figures—Net Sales by Geographic Region, 2009-2011
Table 10.8: Johnson & Johnson Financial Figures—Net Sales by Major Business Segment, 2009-2011
Table 10.9: Johnson & Johnson Financial Figures—Net Sales by Geographic Region, 2009-2011
Table 10.10: Roche Group Financial Figures—Net Sales by Business Sector, 2008-2011
Table 10.11: Roche Group Financial Figures—Net Sales by Geographic Region (Pharmaceuticals), 2009-2011
Table 10.12: Roche Group Financial Figures—Net Sales by Sub-Division (Diagnostics), 2008-2011
Table A1.1: Glucose (Whole Blood) UGL—Glucose (Urine) Over-the-Counter In Vitro Diagnostic Devices
Table A2.1: Cholesterol Over-the-Counter In Vitro Diagnostic Devices
Table A3.1: Fecal Occult Blood Over-the-Counter In Vitro Diagnostic Devices
Table A4.1: Cannabinoids (THC) Over-the-Counter In Vitro Diagnostic Devices
Table A5.1: hCG, Urine Over-the-Counter In Vitro Diagnostic Devices
Table A6.1: Alcohol, Breath Over-the-Counter In Vitro Diagnostic Devices
Table A7.1: Urine Qualitative Dipstick Blood Over-the-Counter In Vitro Diagnostic Devices
Table A8.1: Barbiturates Over-the-Counter In Vitro Diagnostic Devices

Note: Product cover images may vary from those shown

- Abbott Diagnostics
- ACON Laboratories, Inc.
- AgaMatrix
- Alere, Inc.
- American Bio Medica Corporation (ABMC)
- AmeriSourceBergen
- Ani Biotech Oy
- ARKRAY, Inc.
- Bayer Corporation
- Becton Dickinson (BD)
- Biomerica, Inc.
- Calypte Biomedical Corporation
- Cardinal Health, Inc.
- HemoCue
- Home Access Health Corp.
- Insulet Corporation
- International Technidyne Corporation (ITC) Nexus Dx
- Johnson & Johnson
- LifeScan
- A Menarini Diagnostics
- NOVA Biomedical
- Orasure
- Princeton BioMeditech
- Quidel Corp.
- Roche Diagnostics (a Division of Roche Holdings)
- Saliva Diagnostics
- Trinity Biotech, Plc

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos